ArticleFrontiers in genetics2024

Real-world outcomes from a series of patients with late onset Pompe disease who switched from alglucosidase alfa to avalglucosidase alfa.

Chris Carter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.